Kenneth Lee Appointed to Biocryst Pharmaceuticals’ Board of Directors

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that Kenneth B. Lee, Jr., was elected to the Company's board of directors, effective today. He will also serve on the audit committee of the Board.
MORE ON THIS TOPIC